Skip to main content

. 1975 Jun;54(2):275P–276P.

Proceedings: Behavioural and biochemical evidence for cerebral dopamine receptor blockade by metoclopramide in rodents.

P Jenner, C D Marsden, E Peringer

PMCID: PMC1666582 PMID: 1148554

275P

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Borenstein P., Bles G. Effets cliniques et électroencéphalographiques du métoclopramide en psychiatrie. Therapie. 1965 Jul-Aug;20(4):975–995. [PubMed] [Google Scholar]
Casteels-Van Daele M., Jaeken J., Van der Schueren P., Van den Bon P. Dystonic reactions in children caused by metoclopramide. Arch Dis Child. 1970 Feb;45(239):130–133. doi: 10.1136/adc.45.239.130. [DOI] [PMC free article] [PubMed] [Google Scholar]
Costall B., Naylor R. J. Is there a relationship between the involvement of extrapyramidal and mesolimbic brain areas with the cataleptic action of neuroleptic agents and their clinical antipsychotic effect? Psychopharmacologia. 1973;32(2):161–170. doi: 10.1007/BF00428687. [DOI] [PubMed] [Google Scholar]
Janssen P. A., Niemegeers C. J., Schellekens K. H., Lenaerts F. M. Is it possible to predict the clinical effects of neuroleptic drugs (major tranquillizers) from animal data? IV. An improved experimental design for measuring the inhibitory effects of neuroleptic drugs on amphetamine-or apomorphine-induced "Cheroing" and "agitation" in rats. Arzneimittelforschung. 1967 Jul;17(7):841–854. [PubMed] [Google Scholar]

ACTIONS

PDF (307.2 KB)

RESOURCES